SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is a prominent trending stock, fueled by its upcoming inclusion in the S&P MidCap 400, which is sparking community excitement for potential institutional buying. Investors are increasingly bullish on its strong fundamentals, highlighting consistent profitability, a robust balance sheet with no debt, and its leading position in the burgeoning agentic AI sector. The market is actively discussing its long-term growth potential and perceived undervaluation within the automation landscape.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust ($SLV) is surging to unprecedented all-time highs, propelled by tightening global supply due to impending Chinese export restrictions and robust industrial demand from booming sectors like EV batteries, solar, and AI data centers. The community is actively discussing a potential "silver squeeze" and a significant re-rating of silver's value, anticipating further ascent despite some calls for a near-term pullback after its rapid rise.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) are trending as gold achieves new all-time highs, driven by geopolitical concerns, central bank de-dollarization efforts, and expectations of future Fed easing. The community is divided, with many celebrating its "beast mode" rally as a shift to real assets amidst economic uncertainty, while others caution about "irrational exuberance" and a potential bubble.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is actively trending due to widespread anticipation surrounding a crucial FDA meeting for its lead drug, Sonelokimab, with the community highly optimistic about favorable regulatory guidance. This positive sentiment is further amplified by intense speculation regarding a potential acquisition by a major pharmaceutical partner, with recent insider share conversions interpreted by many as a preparatory step for a significant corporate transaction.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

AVNT CRYPTO is generating significant buzz following its recent listing on Robinhood and its strong association with Coinbase, with community members actively discussing upcoming features like an AI trading bot and 500x leveraged perps on the Base app. Despite some historical skepticism, many traders are speculating on its potential for substantial gains, positioning it as a challenger to leading decentralized exchanges within the altcoin space.

Starfighters Space Inc

Starfighters Space Inc. (FJET), a recent aerospace IPO, is fueling intense market volatility and polarizing community discussion. Many believe its low float and high short borrow fees position it for a substantial short squeeze, while a significant portion of the community views it as a pump-and-dump due to its pre-revenue status and speculative nature.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending following significant insider purchases by Apple CEO Tim Cook, a Nike board member, and another director, fueling speculation about an impending turnaround for the struggling sportswear giant. The community is actively debating whether these substantial buys signal extreme confidence in Nike's future and will trigger a technical reversal, despite ongoing concerns about China sales and tariff impacts. Many investors are now evaluating if current prices present a prime buying opportunity or if further declines are anticipated given broader market conditions.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X ($CCCX) is actively trending amid positive research analysis underscoring Infleqtion's immediate commercial applications, particularly in quantum sensing for defense and national security, distinguishing it from peers focused primarily on R&D. The community is buzzing about its significant undervaluation relative to the sector and is eagerly anticipating the upcoming merger, which is expected to attract substantial institutional interest once the ticker transitions to INFQ. This focus on practical, "real-world" quantum solutions positions it as a potential leader in a critical and rapidly expanding technological domain.

Renaissance Capital Greenwich Funds - Renaissance IPO ETF

The Renaissance IPO ETF ($IPO) is trending amid a notable resurgence in the broader IPO market, driven by a flurry of new company and SPAC filings across diverse sectors including AI, technology, and healthcare. Investor sentiment reflects a growing "IPO wave" and renewed "listing hype" for new offerings, as market participants discuss the opportunities and risks associated with this increased activity in initial public offerings.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is experiencing intense community discussion following recent legal document releases, with many online users linking alleged historical activities to the company's namesake. Amidst widespread debate and strong accusations, supporters are actively highlighting the company's fundamental value and recent merger with a nuclear fusion firm as compelling investment opportunities, contrasting with detractors focused on the controversies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Affymax, Inc. is a biopharmaceutical company. It is engaged in the developing of nephrology and specialty care space by delivering innovative therapeutical offerings to patients and healthcare providers. The company was founded on July 20, 2001 and is headquartered in New York, NY.

AFFY
Affymax, Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest AFFY News

AFFYAffymax, Inc.